Trials are about to get underway at UNSW for an oestrogen-based breast cancer drug that could aid in the fight against schizophrenia. The story behind the trials is outlined in the July-August edition of Uniken, which is now online.
Trials are about to get underway at UNSW for an oestrogen-based breast cancer drug that could aid in the fight against schizophrenia. The story behind the trials is outlined in the July-August edition of Uniken, which is now online.
The drug inhibits oestrogen actions in the body but stimulates them in the brain - and could be a way to override a dysfunctional sex hormone that has been found in the brains of people with schizophrenia.
Also in this month's issue we profile the man behind the largest donation in UNSW's history - the $10 million pledge by Frank Lowy towards the Lowy Cancer Research Centre. The discoveries of planet hunter Chris Tinney, the architecture that is transforming campus and breakthroughs in neuroscience are other topics featured.
Click here for the latest issue (1.14Mb)